WO2003044166A3 - METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER - Google Patents
METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER Download PDFInfo
- Publication number
- WO2003044166A3 WO2003044166A3 PCT/US2002/036665 US0236665W WO03044166A3 WO 2003044166 A3 WO2003044166 A3 WO 2003044166A3 US 0236665 W US0236665 W US 0236665W WO 03044166 A3 WO03044166 A3 WO 03044166A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- compositions
- mrna
- gene expression
- level
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002359403A AU2002359403A1 (en) | 2001-11-15 | 2002-11-14 | METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33471201P | 2001-11-15 | 2001-11-15 | |
US60/334,712 | 2001-11-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003044166A2 WO2003044166A2 (en) | 2003-05-30 |
WO2003044166A3 true WO2003044166A3 (en) | 2003-12-31 |
Family
ID=23308474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/036665 WO2003044166A2 (en) | 2001-11-15 | 2002-11-14 | METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002359403A1 (en) |
WO (1) | WO2003044166A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9227956B2 (en) | 2013-04-17 | 2016-01-05 | Pfizer Inc. | Substituted amide compounds |
CN108715830A (en) * | 2018-05-04 | 2018-10-30 | 中南大学湘雅医院 | Urinate extracting method and its application of derived stem cell excretion body |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9085778B2 (en) | 2006-05-03 | 2015-07-21 | VL27, Inc. | Exosome transfer of nucleic acids to cells |
CA2791905A1 (en) | 2010-03-01 | 2011-09-09 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarkers for theranostics |
JP2013526852A (en) | 2010-04-06 | 2013-06-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | Circulating biomarkers for disease |
US20160296560A1 (en) * | 2013-10-02 | 2016-10-13 | Xosoma Pty Ltd | A method of producing exosomes |
JP2018520125A (en) | 2015-06-10 | 2018-07-26 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | Use of exosomes for treatment of disease |
-
2002
- 2002-11-14 AU AU2002359403A patent/AU2002359403A1/en not_active Abandoned
- 2002-11-14 WO PCT/US2002/036665 patent/WO2003044166A2/en not_active Application Discontinuation
Non-Patent Citations (5)
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9227956B2 (en) | 2013-04-17 | 2016-01-05 | Pfizer Inc. | Substituted amide compounds |
CN108715830A (en) * | 2018-05-04 | 2018-10-30 | 中南大学湘雅医院 | Urinate extracting method and its application of derived stem cell excretion body |
CN108715830B (en) * | 2018-05-04 | 2019-08-06 | 中南大学湘雅医院 | Urinate the extracting method and its application of derived stem cell excretion body |
Also Published As
Publication number | Publication date |
---|---|
AU2002359403A1 (en) | 2003-06-10 |
AU2002359403A8 (en) | 2003-06-10 |
WO2003044166A2 (en) | 2003-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005044976A3 (en) | Oligomeric compounds for use in gene modulation | |
ATE421540T1 (en) | METHOD FOR REGULATING THE STABILITY OF EMULSIONS AND STABILIZED EMULSIONS | |
EP1918368A3 (en) | Enzyme stabilization by cationic surfactants | |
IS6950A (en) | Composition of epothilone analogues and chemotherapeutic agents for the treatment of cell proliferative disorders | |
WO2005117938A3 (en) | Methods of treating ocular conditions | |
WO2003044166A3 (en) | METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER | |
WO2004024940A3 (en) | Rna-mediated gene modulation | |
WO2001096604A3 (en) | Assay for genetic polymorphisms using scattered light detectable labels | |
EP1814597A4 (en) | Rnai modulation of the bcr-abl fusion gene and uses thereof | |
ATE381623T1 (en) | METHOD FOR EXPRESSING PROTEIN WITH UNNATURAL AMINO ACID INTEGRATED THEREIN | |
WO2003057843A8 (en) | Methods and materials for modulating trpc4 | |
WO2005042719A3 (en) | Methods for treating and preventing ischemia-reperfusion injury using rna interfering agents | |
WO2001088124A3 (en) | Method and reagent for the inhibition of erg | |
WO2003089903A3 (en) | Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1) | |
AU762955C (en) | Methods and compositions useful for modulation of angiogenesis using tyrosine kinase SRC | |
WO2003006497A3 (en) | Mutated photoproteins and their uses | |
WO2007035962A3 (en) | Gene blocking method | |
AU2003211040A1 (en) | The eaat2 promoter and uses thereof | |
WO2003057847A8 (en) | METHODS AND MATERIALS FOR MODULATING ENaC-BETA | |
DE60210970D1 (en) | MUTANT FORMS OF ETXB AND CTXB AND THEIR USE AS CARRIER | |
WO2001067855A3 (en) | Transgenic mice containing targeted gene disruptions | |
WO2004050834A3 (en) | GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER | |
EP1908835A3 (en) | Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches | |
GB2392911A (en) | Inhibitors of dna methyltransferase isoforms | |
WO2001062911A3 (en) | Antisense and catalytically acting nucleic acid molecules targeted to grb2- related with insert domain (grid) proteins and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |